Circulating MicroRNAs as Specific Biomarkers in Atrial Fibrillation: A Meta-Analysis

Author:

Menezes Junior Antônio da Silva12ORCID,Ferreira Lara Cristina1,Barbosa Laura Júlia Valentim1ORCID,Silva Daniela de Melo e2,Saddi Vera Aparecida1ORCID,Silva Antonio Márcio Teodoro Cordeiro1

Affiliation:

1. Internal Medicine Department, Cardiology and Genetic Section, Pontifical Catholic University of Goiás, Goiânia 74175-120, GO, Brazil

2. Internal Medicine Department, Medicine Faculty and Biological Sciences Institute at Federal University of Goiás, Goiânia 74690-900, GO, Brazil

Abstract

Atrial fibrillation (AF) is the most frequently occurring supraventricular arrhythmia. Although microRNAs (miRNAs) have been associated with AF pathogenesis, standard protocols for quantifying and selecting specific miRNAs for clinical use as biomarkers should be optimized. In this study, we evaluated the clinical application of miRNAs as biomarkers for the prognosis and diagnosis of AF. Literature searches were conducted on PubMed, Cochrane Library, and EMBASE. We included prospective or retrospective observational studies that had been published as of 14 February 2022; our main objective was to analyze the relationship between circulating miRNAs and AF. The data were extracted using the descriptors “Atrial fibrillation AND miRNA”, “Atrial fibrillation AND diagnostic AND miRNA”, and “Atrial fibrillation AND prognosis AND miRNA”. No filters were applied for period delimitation, type of publication, or language. Studies using samples isolated from blood plasma and TaqMan and RT-qPCR for detecting and quantifying miRNAs were selected, and those that used atrial tissue samples were excluded. We identified 272 articles and excluded 102 duplicated articles. Two authors independently read the titles and abstracts of 170 out of 272 articles and selected 56 potential articles, 6 of which were selected for final review. Our analysis revealed a significant association between AF and miR-4798 [OR = 1.90 (95% CI 1.45–2.47)], AF and miRNA-133a [2.77 (2.73–2.82)], AF and miRNA-150 [3.77 (1.50–9.46); I2 = 70%], AF and miRNA-21 [2.23 (1.20–4.17); I2 = 99%], AF and hsa-miRNA4443 [2.32 (2.20–2.44)], and AF and miR-20a-5p [3.67 (1.42–9.49)]. The association between miRNAs and AF showed an OR of 2.51 [95% CI 1.99–3.16; I2 = 99%]. Our meta-analysis demonstrated that circulating miRNAs are potential biomarkers of AF, as they exhibit stable expression post–sample collection. In addition to regulating cellular processes, such as proliferation, differentiation, development, and cell death, miRNAs were found to be linked to arrhythmia development.

Publisher

MDPI AG

Subject

Genetics,Molecular Biology,Biochemistry

Reference30 articles.

1. Atrial fibrillation (Part 1): Pathophysiology, risk factors, and therapeutic basis;Cintra;Arq. Bras. Cardiol.,2021

2. Lozano-Velasco, E., Franco, D., Aranega, A., and Daimi, H. (2020). Genetics and epigenetics of atrial fibrillation. Int. J. Mol. Sci., 21.

3. Atrial fibrillation;Zimetbaum;Ann. Intern. Med.,2017

4. Potential target genes in the development of atrial fibrillation: A comprehensive bioinformatics analysis;Liu;Med. Sci. Monit.,2021

5. Epigenetic mechanisms in atrial fibrillation: New insights and future directions;Tao;Trends Cardiovasc. Med.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3